1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Calliditas Therapeutics AB (publ)
  6. News
  7. Summary
    CALTX   SE0010441584

CALLIDITAS THERAPEUTICS AB (PUBL)

(CALTX)
  Report
Delayed Nasdaq Stockholm  -  05/25 06:59:38 am EDT
85.10 SEK   -3.30%
05/20CALLIDITAS THERAPEUTICS : INTERIM REPORT JANUARY 1ST – MARCH 31ST 2022 - Form 6-K
PU
05/19SECTOR UPDATE : Health Care Stocks Edging Higher Near Thursday Close
MT
05/19SECTOR UPDATE : Health Care Stocks Edging Lower in Thursday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Higher in Thursday Trading

12/16/2021 | 11:04am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC 0.00% 1.47 Delayed Quote.-60.80%
ATAI LIFE SCIENCES N.V. 3.18% 3.88 Delayed Quote.-50.59%
BANCO SANTANDER, S.A. 2.06% 2.953 Delayed Quote.-1.60%
BARCLAYS PLC 0.97% 164.36 Delayed Quote.-12.95%
BICYCLE THERAPEUTICS PLC -3.31% 16.01 Delayed Quote.-72.70%
CALLIDITAS THERAPEUTICS AB (PUBL) -3.30% 85.1 Delayed Quote.-21.99%
EDAP TMS S.A. 0.57% 7.04 Delayed Quote.16.86%
ENDAVA PLC -0.89% 89.45 Delayed Quote.-46.21%
LLOYDS BANKING GROUP PLC 0.64% 44.29 Delayed Quote.-7.93%
SEQUANS COMMUNICATIONS S.A. -3.77% 2.81 Delayed Quote.-38.40%
SPARK NETWORKS SE 6.15% 1.9 Delayed Quote.-42.99%
STMICROELECTRONICS N.V. 0.58% 35.785 Real-time Quote.-17.96%
TRINITY BIOTECH PLC 0.78% 1.3 Delayed Quote.-9.79%
VERONA PHARMA PLC 2.39% 4.28 Delayed Quote.-37.80%
VOXELJET AG 1.15% 3.96 Delayed Quote.-33.64%
ZEALAND PHARMA A/S 1.98% 92.5 Delayed Quote.-37.49%
All news about CALLIDITAS THERAPEUTICS AB (PUBL)
05/20CALLIDITAS THERAPEUTICS : INTERIM REPORT JANUARY 1ST – MARCH 31ST 2022 - Form 6-K
PU
05/19SECTOR UPDATE : Health Care Stocks Edging Higher Near Thursday Close
MT
05/19SECTOR UPDATE : Health Care Stocks Edging Lower in Thursday Trading
MT
05/19Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)
AQ
05/19Calliditas Therapeutics AB Announces Board Changes
CI
05/19Calliditas Therapeutics Receives Positive European Medicines Agency Opinion for Kidney ..
MT
05/19Calliditas Therapeutics Up 13% After European Medicines Agency Committee Gives Positive..
MT
05/19Calliditas receives positive CHMP opinion in IgA nephropathy
AQ
05/19Calliditas Therapeutics AB Receives Positive CHMP Opinion in IgA Nephropathy
CI
05/18Calliditas Therapeutics - First patient randomized in Phase 2 trial in head and neck ca..
AQ
More news
Analyst Recommendations on CALLIDITAS THERAPEUTICS AB (PUBL)
More recommendations
Financials
Sales 2022 585 M 59,7 M 59,7 M
Net income 2022 -567 M -57,9 M -57,9 M
Net cash 2022 173 M 17,7 M 17,7 M
P/E ratio 2022 -9,07x
Yield 2022 -
Capitalization 4 679 M 478 M 478 M
EV / Sales 2022 7,71x
EV / Sales 2023 2,22x
Nbr of Employees 71
Free-Float 80,7%
Chart CALLIDITAS THERAPEUTICS AB (PUBL)
Duration : Period :
Calliditas Therapeutics AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CALLIDITAS THERAPEUTICS AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 88,00 SEK
Average target price 207,50 SEK
Spread / Average Target 136%
EPS Revisions
Managers and Directors
Renée Julie Elisabet Aguiar-Lucander Chief Executive Officer
Fredrik Johansson Chief Financial Officer
Elmar J. Schnee Chairman
Johan Erik Häggblad Chief Scientific Officer
Richard Philipson Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
CALLIDITAS THERAPEUTICS AB (PUBL)-21.99%478
MERCK KGAA-22.86%81 724
KYOWA KIRIN CO. LTD.-11.58%11 660
SK BIOPHARMACEUTICALS CO., LTD.-12.04%5 383
YUHAN CORPORATION-4.83%3 218
BETTA PHARMACEUTICALS CO., LTD.-44.12%2 953